Elsevier

Respiratory Medicine

Volume 87, Issue 3, April 1993, Pages 217-221
Respiratory Medicine

Original article
Respiratory function at follow-up after neonatal surfactant replacement therapy

https://doi.org/10.1016/0954-6111(93)90095-HGet rights and content

Abstract

Respiratory function was assessed at a median of 7 months (range 6–12) in 17 preterm infants who, in the neonatal period, had been entered into a multi-centre randomized placebo-controlled trial of prophylactic surfactant replacement therapy. Seven infants (median gestational age 28 weeks) received surfactant and the remaining ten infants (median gestational age 27 weeks) placebo. Respiratory function was assessed by measuring functional residual capacity (FRC), thoracic gas volume (TGV) and airways resistance (Raw). Specific conductance (SGaw) was calculated from Raw and TGV. There was no significant difference in FRC or TGV between the two groups. Raw, however, was significantly lower in the surfactant (median 41, range 21–48 cmH2O l−1 s−1) compared to the placebo group (median 57, range 40–68 cmH2O l−1 s−1),P < 0·05 and SGaw significantly higher in the surfactant (median 0·136, range 0·063–0·289 l cmH2O−1 s−1) compared to the placebo group (median 0·081, range 0·062-0·134 l cmH2O−1 s−1), P < 0·05. These results suggest that surfactant replacement therapy improves lung function at follow-up.

References (26)

  • MorleyCJ et al.

    Respiratory compliance measurements in very premature babies treated with artificial surfactant (ALEC)

    Arch Dis Child

    (1991)
  • EdbergKE et al.

    Immediate effects on lung function of instilled human surfactant in mechanically ventilated newborn infants with IRDS

    Acta Paediatr Scand

    (1990)
  • DavisJM et al.

    Changes in pulmonary mechanics after the administration of surfactant to infants with respiratory distress syndrome

    N Engl J Med

    (1988)
  • Cited by (21)

    • Exogenous surfactant therapy

      2022, Goldsmith's Assisted Ventilation of the Neonate: An Evidence-Based Approach to Newborn Respiratory Care, Seventh Edition
    • Quantifying neonatal pulmonary mechanics in mechanical ventilation

      2019, Biomedical Signal Processing and Control
      Citation Excerpt :

      Patients who received surfactant treatment had lower specific elastance (99% CI difference in medians: -0.49 [-0.48 -0.48] cmH2O.kg/ml) compared to those that did not (Patients 5 & 8 vs Patients 2, 3, 4, 6, 7, 9, & 10) with p ≤ 0.01. This result matches expected behaviour as surfactant lowers the surface tension, thus lowering the pressure required to keep alveoli and airways open [6,47,48]. Elastance decreased with increasing patient weight.

    • Pharmacologic Therapies I: Surfactant Therapy

      2017, Assisted Ventilation of the Neonate: An Evidence-Based Approach to Newborn Respiratory Care: Sixth Edition
    • Pharmacologic Adjuncts II. Exogenous Surfactants

      2011, Assisted Ventilation of the Neonate
    • Pharmacologic adjuncts ii: Exogenous surfactants exogenous surfactants

      2010, Assisted Ventilation of the Neonate: Expert Consult - Online and Print
    • Pharmacologic Adjuncts II: Exogenous Surfactants

      2003, Assisted Ventilation of the Neonate
    View all citing articles on Scopus
    View full text